Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by sah1on Dec 22, 2017 8:23am
294 Views
Post# 27213062

RE:The big clog on this BB

RE:The big clog on this BBDrybones, being a real oldtimer in this stock, I along with many others on this BB, went thru much dire circumstances than those who who recently took an initial position in PLI at $3+. I mean we saw the stock plumment from over $2.50 to 8 cents and for years we endured the company being on the knife edge - a step away from total bankruptcy. But we held the faith and when PLI's future became clearer in 2012, many of us took a bold step and bought a lot of shares at very low prices.

I didn't think we would see that situation again. While I am very, very annoyed at the current share price, the buying opportunity can't be overlooked. PLI is not anywhere near bankruptcy. Indeed it is on the verge of commercialising its first plasma protein Pg, soon to be followed by IVIG. In addition, 4050 is looking to be a very promising drug for fibrosis and could see its first approval in Alstrom in the UK in 2018. The recent Paradigm update that I posted gives insights as to when PLI will become cashflow positive. Take a close look at this report and come to your own conclusions.

So those shareholders with faint hopes, step back and carefully assess the opportunity before you. It could well be the best XMAS gift you could ever give yourself:-)
Bullboard Posts